Acinetobacter baumannii produces carbapenemase-hydrolyzing class D β-lactamases
(CHDLs) as one of the major drug resistance mechanisms. This investigation is thus aimed …

Twenty blood isolates of Acinetobacter baumannii were studied, representing eight pulsed-
field gel electrophoresis patterns and all different antimicrobial susceptibility patterns …

At a children's hospital in Riga, Latvia, isolates identified as Salmonella typhimurium were
found to be resistant to expanded-spectrum cephalosporins. Two of the resistant strains …

Acinetobacter spp. are emerging as opportunistic hospital pathogens that demonstrate
resistance to many classes of antibiotics. In a metropolitan hospital in Cleveland, a clinical …

Carbapenem-resistant Acinetobacter baumannii isolates were obtained from 17 patients
between September 2004 and August 2005 at the Academisch Ziekenhuis Vrije Universiteit …

The increasing trend of carbapenem resistance in Acinetobacter baumannii worldwide is a
concern since it limits drastically the range of therapeutic alternatives. Metallo-β-lactamases …

ABSTRACT A cefotaxime-resistant, ceftazidime-susceptible Escherichia coli isolate was
obtained from a patient with sepsis in 1997, from which a β-lactamase with a pI of 8.1 was …

We investigated the basis of the carbapenem resistance of 17 multidrug-resistant
Acinetobacter baumannii clinical isolates collected from 2004 to 2005 at the Saint George …

Plasmid-mediated carbapenem-hydrolyzing β-lactamases are becoming emerging threats
with Enterobacteriaceae. In particular, the carbapenem-hydrolyzing class D β-lactamase …

Two epidemiologically unrelated carbapenem-resistant Acinetobacter baumannii isolates
were investigated as representatives of the first Italian isolates producing the OXA-24 …